"Recent Advances in Medicinal Chemistry is a book series focused on leading-edge research on developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies. The series presents highly cited contributions first published in the impact factor journal Mini-Reviews in Medicinal Chemistry. Contributors to this volume have updated their work with new experimental data and references following their initial research. Each volume highlights a number of important topics in current research in medicinal chemistry.
Selected chapters in this volume include:
- Characterization of Inorganic Nanomaterials as Therapeutic Vehicles
- HPLC and its Essential Role in the Analysis of Tricyclic Antidepressants in Biological Samples
- Tannins and Their Influence on Health
… And much more."


Recent Advances in Medicinal Chemistry: Volume 1

End User License Agreement (for non-institutional, personal use)

2.. Principal functions of NSAIDs and aureolic acid anticancer antibiotics and their mechanism of action

3.. OTHER FUNCTIONS OF THESE DRUGS AND MECHANISM OF ACTIONS

4.. Chemical Dissection of the drugs to understand alternate functions

New Functions of Old Drugs: Aureolic Acid Group of Anti-Cancer Antibiotics and Non-Steroidal Anti-Inflammatory Drugs

A REDOX-SENSING MOLECULAR SWITCH FORMED VIA AN INTERMOLECULAR DISULFIDE BOND

Low redox potential sulfenate formation at a catalytic site cysteine: Another mechanism by which MST serves as an anti-oxidant protein

Updated Report on a Novel Mercaptopyruvate Sulfurtransferase Thioredoxin-Dependent Redox-Sensing Molecular Switch: A Mechanism for the Maintenance of Cellular Redox Equilibrium

Characterization of Inorganic Nanomaterials as Therapeutic Vehicles

Aromatase Inhibitors: A New Reality for the Adjuvant Endocrine Treatment of Early-Stage Breast Cancer in Postmenopausal Women

BACTERIAL TYPE II FAS THE BIOLOGICAL PROCESS

FABH AS A DRUG TARGET DIFFERENCES AND ADVANTAGES

CATALYTIC MECHANISM AND SUBSTRATE BINDING

Bacterial FabH: Towards the Discovery of New Broad-Spectrum Antibiotics

Rho-GTPases and Statins: A Potential Target and a Potential Therapeutic Tool Against Tumors?

Types of Carotenoids and Their Distribution in Diets

Carotenoids that are Involved in Prostate Cancer Risk

Diverse Structures and Functions of Saponins

Combinations of saponins and other anti-cancer agents

Preclinical Studies of Saponins for Tumor Therapy

5.. CURRENT TREATMENT OF ACUTE SPINAL CORD INJURIES

6.. PROMISING FUTURE PHARMACOLOGICAL THERAPIES

Pharmacological Neuroprotection for Acute Spinal Cord Injury

HPLC and its Essential Role in the Analysis of Tricyclic Antidepressants in Biological Samples

Global gene expression profiling of ER action

Gene Expression Profiles in Breast Cancer to Identify Estrogen Receptor Target Genes

Trans-Plasma Membrane Electron Transport in Human Blood Platelets: An Update

Role of Intermediate States in Protein Folding and Misfolding

Bentham Science Publishers

Frontiers in Anti-Cancer Drug Discovery” is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.


Frontiers in Anti-Cancer Drug Discovery: Volume 2

Atta-ur-Rahman

Dr. M. lqbal Choudhary 

"Frontiers in Clinical Drug Research – Anti infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
The second volume of this series features reviews that cover a variety of topics including: 
-Identification of nosocomial pathogens and antimicrobials using phenotypic techniques
-Topical antimicrobials
-Anti-infective drug safety
-Antimicrobial resistance
… and much more."


Frontiers in Clinical Drug Research - Anti Infectives: Volume 2

"The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results.
Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. The feast of these reader-friendly reviews on topics of great scientific importance – many of which are considered significant medical breakthroughs, makes this series excellent reading both for the novice as well as for expert medicinal chemists and clinicians.
This volume brings together 5 reviews on the following topics:
- Retinal angiogenesis
- Effects of brief daily EMF therapy on tumor growths
- Evolution of the role of angiogenesis in cancer treatments over six decades
- Anti-angiogenesis drugs
- Anti-angiogenesis therapy for multiple sclerosis
- Update on the link between angiogenesis and portal hypertension"


Anti-Angiogenesis Drug Discovery and Development: Volume 4

"Frontiers in Natural Product Chemistry is a book series devoted to publishing monographs that highlight important advances in natural product chemistry. The series covers all aspects of research in the chemistry and biochemistry of naturally occurring compounds, including research on natural substances derived from plants, microbes and animals. Reviews of structure elucidation, biological activity, organic and experimental synthesis of natural products as well as developments of new methods are also included in the series.
 
 
 
The sixth volume of the series brings five reviews covering these topics:
 
 
 
- Plant protein hydrolyzates from underutilized agricultural and agroindustrial sources: production, characterization and bioactive properties
 
- New developments in the quinolone class of antibacterial drugs
 
- Structure of fine starch prepared via a compressed hot water process
 
- Major metabolites of certain marketed plant alkaloids
 
- Natural products in cancer chemoprevention and chemotherapy"


Frontiers in Natural Product Chemistry: Volume 6

"Herbal Medicine: Back to the Future compiles expert reviews on the application of herbal medicines (including Ayurveda, Chinese traditional medicines and alternative therapies) to treat different ailments. The book series demonstrates the use of sophisticated methods to understand traditional medicine, while providing readers a glimpse into the future of herbal medicine.
 
The second volume in the series continues on the theme of the previous volume, focusing on herbal remedies for cardiovascular health. The topics included in this volume are:
 
        Plants used for treating cardiovascular diseases in the Iberian Peninsula and Balearic Islands
        Herbal products for treating hypertension and hyperlipidemia
        Medicinal plants and the Mediterranean diet for treating obesity related cardiovascular disorders
        Traditional Indian cardiovascular medicine 
 
This volume is essential reading for all researchers in the field of ethnobotany, natural product chemistry, nutrition and pharmacology. Medical professionals involved in cardiology and internal medicine who seek to improve their knowledge about herbal medicine and alternative therapies will also benefit from the contents of the volume.  "


Herbal Medicine: Back to the Future: Volume 2, Vascular Health

Ferid Murad

Ka Bian

"Frontiers in Anti-Cancer Drug Discovery” is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The fifth volume of the series features chapters on the following topics:
-Nutraceuticals and natural food products for cancer treatment
-Pharmacogenomics in Anti-cancer treatment
-Cancer stem cells
-Potassium channel targeting for brain tumor treatment
-Sorafenib in the management of hepatocellular carcinoma
…and more.
 "


Frontiers in Anti-Cancer Drug Discovery: Volume 5

"Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic predisposition, endocrine disorders, medications and psychiatric illnesses. Onset of obesity in both the developing and the developed world has reached epidemic proportions. In response to this, efforts to control and treat obesity have also been vigorously pursued, ranging from raising awareness about lifestyle changes to the discovery and development of safe and effective anti-obesity drugs.
Anti-obesity Drug Discovery and Development is focused on this very important area of healthcare research. The third volume of this series is dedicated to anti-obesity treatments including updates on new therapeutics for obesity, Nesfatin-1 and its therapeutic uses, the role of proteomics in pediatric anti-obesity treatment, the role of oxidative stress in childhood obesity and a review of data on gut microbiota as a treatment option for obesity."


Anti-obesity Drug Discovery and Development: Volume 3

"Frontiers in Clinical Drug Research - Anti-Cancer Agents - Volume 1 should prove to be a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field. The chapters in this volume have been written by leading experts from the field.
The contents of this book include new approaches to cancer therapy, treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors, targeting key signaling pathways in pediatric brain tumors, current status of cladribine in lymphoid and myeloid malignancies, natural anti-cancer products and the mechanisms of telomere and telomerase regulation in hematologic malignancies. 
The eBook series is essential to all scientists involved in clinical drug research who wish to keep abreast of rapid and important developments in the field. The readers will find these reviews valuable and  will certainly trigger further research in the pharmaceutical development of anti-cancer agents."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 1

"Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.
 
The second volume of this series features 7 reviews presenting updates on hormones and several classes of drugs:
 
    Osteocalcin action in glucose metabolism
    Sodium-glucose co-transporter 2 (SGLT2) inhibitors
    Glucagon-like peptide-1 (GLP-1) mimetics
    Dipeptidyl peptidase 4 (DPP-4) inhibitors
    New drugs in clinical trial and commercial phases"


Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 2

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
The sixth volume of this series features reviews that cover the following topics:
-Depression, Insomnia and Atypical Antidepressants
-Combination Therapy of Hypothermia for Hypoxic Encephalopathy in Neonates
-Development of A “Theranostic Nano-Bullet” for Tinnitus
-Dexmedetomidine: From Basic Science to Clinical Application of Brain Protection
-Protein Misfolding, Aggregation, Amyloid Formation in Neurodegenerative Diseases 
 "


Your Cart

Recent Advances in Medicinal Chemistry: Volume 1

$ 199.00

Description of Recent Advances in Medicinal Chemistry: Volume 1

Additional Information

About the authors

Atta-ur-Rahman

Frontiers in Anti-Cancer Drug Discovery: Volume 2

Frontiers in Clinical Drug Research - Anti Infectives: Volume 2

Anti-Angiogenesis Drug Discovery and Development: Volume 4

Frontiers in Natural Product Chemistry: Volume 6

Herbal Medicine: Back to the Future: Volume 2, Vascular Health

Frontiers in Anti-Cancer Drug Discovery: Volume 5

Anti-obesity Drug Discovery and Development: Volume 3

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 1

Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 2

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 6

Atta-ur-Rahman